Cancer drug manufacturer Array is up 20.6% at $25.28, earlier hitting a record high of $25.86, after saying its triple combo therapy drug met its main goals in its late-stage trial. ARRY has had an …

More 3 Drug Stocks Seeing Unusual Options Trading Today Videos